Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-25-228340

Co-Chief Executive Officer sold 29,933 shares at an average $14.35 ($429,469)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Joshua B Co-Chief Executive Officer 2025-09-30 Sale −29,733 $14.34 $426,469 3,325,547 D
Cohen Joshua B Co-Chief Executive Officer 2025-09-30 Sale −200 $15.00 $3,000 3,325,347 D
Open-market sales · 29,933 sh · avg $14.35 · $429,469
Loading xslF345X05/ownership.xml…